Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors

被引:37
|
作者
Alfano, Catherine M.
McGregor, Bonnie A.
Kuniyuki, Alan
Reeve, Bryce B.
Bowen, Deborah J.
Baumgartner, Kathy B.
Bernstein, Leslie
Ballard-Barbash, Rachel
Malone, Kathleen E.
Ganz, Patricia A.
McTiernan, Anne
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] NCI, Outcomes Res Branch, ARP, DCCPS, Bethesda, MD 20892 USA
[3] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA
[4] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA
[5] NCI, Appl Res Program, Bethesda, MD 20892 USA
关键词
breast cancer; hormone symptoms; psychometrics; oncology; survivorship; cancer;
D O I
10.1002/pon.1033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hormone-related symptoms are common in breast cancer survivors and many aspects of these symptoms are currently under study. Reliable and valid assessment tools are needed to successfully study hormone-related symptoms in breast cancer survivors; however, no gold standard currently exists for measuring these symptoms. This study evaluated the psychometric properties of a shortened version of the Breast Cancer Prevention Trial (BCPT) symptom checklist in a sample of 803 breast cancer survivors. Principal factor analysis with Promax oblique rotation revealed a five-factor structure, identifying five separate hormone-related symptoms scales: vasomotor symptoms, urinary incontinence, cognitive/mood changes, vaginal symptoms, and weight gain/appearance concern. Hormone-related symptom scale scores differed by demographic and clinical characteristics according to expectations, suggesting that these five scales from the shortened BCPT checklist are reasonably reliable and valid. Symptom scale scores were only weakly correlated with health-related quality of life scores; however, the pattern of results generally supported the validity of the symptom scales. This study adds to the evidence that breast cancer survivors experience a significant number of hormone-related symptoms. Future clinical trials and quality of life and symptom management intervention studies would benefit from accurate assessment of hormone-related symptoms with the five scales from the shortened BCPT checklist. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:985 / 1000
页数:16
相关论文
共 50 条
  • [1] Prevention of hormone-related cancers: Breast cancer
    Dunn, BK
    Wickerham, L
    Ford, LG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (02) : 357 - 367
  • [2] Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: a HEAL study report
    Ma, Huiyan
    Sullivan-Halley, Jane
    Smith, Ashley W.
    Neuhouser, Marian L.
    Alfano, Catherine M.
    Meeske, Kathleen
    George, Stephanie M.
    McTiernan, Anne
    McKean-Cowdin, Roberta
    Baumgartner, Kathy B.
    Ballard-Barbash, Rachel
    Bernstein, Leslie
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 11
  • [3] Hormone-related symptoms and health-related quality of life in a multiethnic cohort of breast cancer survivors, 2 years post-diagnosis
    Alfano, CM
    McGregor, BA
    Kuniyuki, A
    Reeve, BB
    Baumgartner, KB
    Bernstein, L
    Ballard-Barbash, R
    McTiernan, A
    Bowen, DJ
    PSYCHO-ONCOLOGY, 2005, 14 (01) : S90 - S90
  • [4] ESTROGENIC BOTANICAL SUPPLEMENTS, HEALTH-RELATED QUALITY OF LIFE, FATIGUE, AND HORMONE-RELATED SYMPTOMS IN BREAST CANCER SURVIVORS: A HEAL STUDY REPORT
    Ma, H.
    Sullivan-Halley, J.
    Smith, A. W.
    Neuhouser, M. L.
    Meeske, K.
    McKean-Cowdin, R.
    Alfano, C. M.
    George, S. M.
    Ballard-Barbash, R.
    Bernstein, L.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S86 - S86
  • [5] Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: a HEAL study report
    Huiyan Ma
    Jane Sullivan-Halley
    Ashley W Smith
    Marian L Neuhouser
    Catherine M Alfano
    Kathleen Meeske
    Stephanie M George
    Anne McTiernan
    Roberta McKean-Cowdin
    Kathy B Baumgartner
    Rachel Ballard-Barbash
    Leslie Bernstein
    BMC Complementary and Alternative Medicine, 11
  • [6] Hormone-related factors associated with hormone receptor levels in breast cancer
    Calzada, L
    Martinez, JM
    Sandoval, T
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2001, 52 (04) : 264 - 268
  • [7] Genetic Variants in Hormone-Related Genes and Risk of Breast Cancer
    Clendenen, Tess
    Zeleniuch-Jacquotte, Anne
    Wirgin, Isaac
    Koenig, Karen L.
    Afanasyeva, Yelena
    Lundin, Eva
    Arslan, Alan A.
    Axelsson, Tomas
    Forsti, Asta
    Hallmans, Goran
    Hemminki, Kari
    Lenner, Per
    Roy, Nirmal
    Shore, Roy E.
    Chen, Yu
    PLOS ONE, 2013, 8 (07):
  • [8] Symptoms related to tamoxifen use in breast cancer survivors
    Chait, SR
    King, HM
    Andrykowski, MA
    Jacobsen, PB
    PSYCHO-ONCOLOGY, 2006, 15 (01) : S32 - S33
  • [9] Psychometric Properties of the Image of God Scale in Breast Cancer Survivors
    Schreiber, Judy A.
    ONCOLOGY NURSING FORUM, 2012, 39 (04) : 399 - 399
  • [10] PARATHYROID HORMONE-RELATED PROTEIN - DETECTION AND PROGNOSIS IN BREAST-CANCER
    DOWNEY, SE
    WALLS, J
    RATCLIFFE, WA
    EDWARDS, R
    BUNDRED, NJ
    BRITISH JOURNAL OF SURGERY, 1995, 82 (11) : 1571 - 1572